Unknown

Dataset Information

Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.


ABSTRACT:

Rationale

Atherosclerosis is a chronic inflammatory disease of the arterial wall. Several proinflammatory cytokines are known to promote atherosclerosis, but less is known about the physiological role of anti-inflammatory cytokines. Interleukin (IL)-27 is a recently discovered member of the IL-6/IL-12 family. The IL-27 receptor is composed of IL-27 receptor A (WSX-1) and gp130 and is required for all established IL-27 signaling pathways. The expression of the IL-27 subunit Ebi3 is elevated in human atheromas, yet its function in atherosclerosis remains unknown.

Objective

The aim of this study was to test the role of IL-27 receptor signaling in immune cells in atherosclerosis development.

Methods and results

Atherosclerosis-prone Ldlr(-/-) mice transplanted with Il27ra

SUBMITTER: Koltsova EK 

PROVIDER: S-EPMC3750996 | biostudies-literature | 2012 Oct

REPOSITORIES: biostudies-literature